GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
SDGZX
Price
$125.11
Change
-$3.07 (-2.40%)
Updated
Feb 21 closing price
Net Assets
2.26B
Ad is loading...

GFACX vs SDGZX

Header iconGFACX vs SDGZX Comparison
Open Charts GFACX vs SDGZXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
DWS Capital Growth R6
Price$125.11
Change-$3.07 (-2.40%)
VolumeN/A
Net Assets2.26B
GFACX vs SDGZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. SDGZX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and SDGZX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. SDGZX (2.26B). GFACX (0.00) and SDGZX (0.00) have matching dividends . GFACX was incepted earlier than SDGZX: GFACX (24 years) vs SDGZX (11 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. SDGZX (17.00). SDGZX has a lower initial minimum investment than GFACX: SDGZX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. SDGZX (8.75). SDGZX return over 5 years is better than : 36.20 vs. GFACX (32.83).
GFACXSDGZXGFACX / SDGZX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years11 years-
Gain YTD2.9802.214135%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets304B2.26B13,475%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.158.75116%
Returns for 3 years17.6916.33108%
Returns for 5 years32.8336.2091%
Returns for 10 years55.6366.5484%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding